https://www.who.int/news-room/fact-sheets/detail/breast-cance, "Breast cancer". World Health Organization. 12 March 2024. Retrieved 29 March 2024).

World Health Organisation (2021): The global cancer observatory, source: Globocan 2020, 356-india-fact-sheets.pdf. Factsheet-India. World Health Organisation. https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf. Accessed 17 Jan 2023.

Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G (May 2021). "Breast cancer". Lancet. 397 (10286):1750–1769. doi:10.1016/S0140-6736(20)32381-3. PMID 33812473. S2CID 232485291.

Parker JS, Mullins M, Cheang MCU et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27:1160–1167

Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ Panel members. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736–1747. doi: 10.1093/annonc/mdr304.

Goldstein NS, Decker D, Severson D et al (2007) Molecular clas sification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 110:1687–1696

Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434

D’ Orsi CJ, Sickles EA, Mendelson EB, Morris EA (2013) ACR BI-RADS® Atlas, [11] breast imaging reporting and data system. 5th ed. Reston, VA: American College of Radiology; 2013.

Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, et al. Subtypes of Breast Cancer. In: Mayrovitz HN, editor. Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. Chapter 3. Available from: https://www.ncbi.nlm.nih.gov/books/NBK583808/# doi: 10.36255/exon-publications-breast-cancer-subtypes.

Cho N. Imaging features of breast cancer molecular subtypes: state of the art. J Pathol Transl Med. 2021 Jan;55(1):16-25. doi: 10.4132/jptm.2020.09.03. Epub 2020 Nov 9. PMID: 33153242; PMCID: PMC7829574.

Erber R, Hartmann A. Histology of Luminal Breast Cancer. Breast Care (Basel). 2020 Aug;15(4):327-336. doi: 10.1159/000509025. Epub 2020 Jul 15. PMID: 32982642; PMCID: PMC7490665.

Lo Gullo R, Daimiel I, Morris EA, Pinker K. Combining molecular and imaging metrics in cancer: radiogenomics. Insights Imaging. 2020 Jan 3;11(1):1. doi: 10.1186/s13244-019-0795-6. PMID: 31901171; PMCID: PMC6942081.

Adrada BE, Moseley TW, Kapoor MM, Scoggins ME, Patel MM, Perez F, Nia ES, Khazai L, Arribas E, Rauch GM, Guirguis MS. Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment. Radiographics. 2023 Oct;43(10):e230034. doi: 10.1148/rg.230034. PMID: 37792593; PMCID: PMC10560981.

Schopp JG, Polat DS, Arjmandi F, Hayes JC, Ahn RW, Sullivan K, Sahoo S, Porembka JH. Imaging Challenges in Diagnosing Triple-Negative Breast Cancer. Radiographics. 2023 Oct;43(10):e230027. doi: 10.1148/rg.230027. PMID: 37708071.

Tamaki K, Ishida T, Miyashita M, Amari M, Ohuchi N, Tamaki N, Sasano H. Correlation between mammographic findings and corresponding histopathology: potential predictors for biological characteristics of breast diseases. Cancer Sci. 2011 Dec;102(12):2179-85. doi: 10.1111/j.1349-7006.2011.02088.x. Epub 2011 Oct 6. PMID: 21895869.

Liu S, Wu XD, Xu WJ, Lin Q, Liu XJ, Li Y. Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer? Korean J Radiol. 2016 Nov-Dec;17(6):846-852. doi: 10.3348/kjr.2016.17.6.846. Epub 2016 Oct 31. PMID: 27833400; PMCID: PMC5102912.

Qi YJ, Su GH, You C, Zhang X, Xiao Y, Jiang YZ, Shao ZM. Radiomics in breast cancer: Current advances and future directions. Cell Rep Med. 2024 Sep 17;5(9):101719. doi: 10.1016/j.xcrm.2024.101719. PMID: 39293402; PMCID: PMC11528234.

Rana N, Thakur S, Thakur V. et al. Mammographic parameters as predictors of molecular subtype of breast cancer: a prospective analysis. Surg Exp Pathol 7, 22 (2024). https://doi.org/10.1186/s42047-024-00169-x.

Rayamajhi, K., Bansal, R., & Aggarwal, B. (2023). Mammographic correlation with molecular subtypes of breast carcinoma. Journal of Radiology and Oncology, 7(1), 001–005. https://doi.org/10.29328/journal.jro.1001045

Boisserie-Lacroix M, Macgrogan G, Debled M, Ferron S, Asad-Syed M, McKelvie-Sebileau P, Mathoulin-Pélissier S, Brouste V, Hurtevent-Labrot G. Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers. Oncologist. 2013;18(7):802-11. doi: 10.1634/theoncologist.2013-0380. Epub 2013 Jul 2. PMID: 23821326; PMCID: PMC3720633.

Cen D, Xu L, Li N, Chen Z, Wang L, Zhou S, Xu B, Liu CL, Liu Z, Luo T. BI-RADS 3-5 microcalcifications can preoperatively predict breast cancer HER2 and Luminal a molecular subtype. Oncotarget. 2017 Feb 21;8(8):13855-13862. doi: 10.18632/oncotarget.14655. PMID: 28099938; PMCID: PMC5355144.

All Articles

Mammographic Patterns Reflecting Molecular Subtypes in Breast Cancer: A Cross-Sectional Study

Explore Journal